We have located links that may give you full text access.
Rejuvenation of the perioral and lip regions with two new dermal fillers: The Italian experience with Vycross ™ Technology.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology 2017 Februrary
BACKGROUND: Hyaluronic acid fillers are frequently used for maintenance of youthful appearance of perioral and lip region. The introduction of Juvederm® Volbella™ with lidocaine and Juvederm® Volift™ with lidocaine to the European aesthetic market in 2012 increased the options of fillers to be used and it appears to be a new solution to improve this area.
OBJECTIVE: the aim of this study is to demonstrate how to correct this area using two new dermal fillers: Juvederm® Volift™ with lidocaine, and Juvederm® Volbella™ with lidocaine, based on the experience of two Italian phycians.
MATERIAL AND METHODS: 510 patients were enrolled, 195 were treated with Juvederm® Volbella™ with Lidocaine, 160 with Juvederm® Volift™ with lidocaine and 150 with both dermal fillers. Patients were photographed before and immediately after the treatment.
RESULTS: All patients were extremely satisfied with their treatments. There were no immediate or delayed complications with either of the dermal fillers when used alone, or in combination.
CONCLUSION: The dermal filler portfolio in Europe is among the largest and most varied available. ( 5 ) We propose here two new 15mg/ml and 17.5mg/ml hyaluronic acid fillers that utilize Vycross™ technology, that are suitable for lip and perioral region. According to the severity of the wrinkles and to the lip augmentation that we want to obtain we can select either one filler or another.
OBJECTIVE: the aim of this study is to demonstrate how to correct this area using two new dermal fillers: Juvederm® Volift™ with lidocaine, and Juvederm® Volbella™ with lidocaine, based on the experience of two Italian phycians.
MATERIAL AND METHODS: 510 patients were enrolled, 195 were treated with Juvederm® Volbella™ with Lidocaine, 160 with Juvederm® Volift™ with lidocaine and 150 with both dermal fillers. Patients were photographed before and immediately after the treatment.
RESULTS: All patients were extremely satisfied with their treatments. There were no immediate or delayed complications with either of the dermal fillers when used alone, or in combination.
CONCLUSION: The dermal filler portfolio in Europe is among the largest and most varied available. ( 5 ) We propose here two new 15mg/ml and 17.5mg/ml hyaluronic acid fillers that utilize Vycross™ technology, that are suitable for lip and perioral region. According to the severity of the wrinkles and to the lip augmentation that we want to obtain we can select either one filler or another.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app